News
0
MSD’s anti-PD-1 therapy Keytruda has secured another approval from the FDA, this time as a first-line treatment in combination with Pfizer’s Inlyta...
0
Healthcare conglomerate Johnson & Johnson has agreed to pay $9.9 million to settle a Washington state lawsuit over the firm’s alleged...
0
Pfizer’s vice president and head of immune-oncology clinical development has joined Aduro Biotech as the company’s new Chief Medical Officer, just...
0
Patients with Parkinson’s have been able to walk after receiving electrical stimulation to their spines.
Features
Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research...
Featured Appointment
Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO.
The opioid drugmaker said the decision...
Service Company News
Featured Event
25/09/2019 - 26/09/2019 -
London,
@Pharmafocus
